The non-immunosuppressive cyclosporin DEBIO-025 is a potent inhibitor of hepatitis C virus replication in vitro (Q34504825)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	The non-immunosuppressive cyclosporin DEBIO-025 is a potent inhibitor of hepatitis C virus replication in vitro	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16557546

retrieved

2 August 2017

title

The non-immunosuppressive cyclosporin DEBIO-025 is a potent inhibitor of hepatitis C virus replication in vitro (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16557546

retrieved

2 August 2017

main subject

Hepatitis C virus

1 reference

based on heuristic

inferred from title

virus

1 reference

based on heuristic

inferred from title

hepatitis C

1 reference

based on heuristic

inferred from title

author

Jan Paeshuyse

object named as

Jan Paeshuyse

series ordinal

1

0 references

Ralf Bartenschlager

object named as

Ralf Bartenschlager

series ordinal

7

0 references

Erik De Clercq

object named as

Erik De Clercq

series ordinal

3

0 references

Johan Neyts

object named as

Johan Neyts

series ordinal

8

0 references

Jean-Maurice Dumont

series ordinal

5

object named as

Jean-Maurice Dumont

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16557546

retrieved

2 August 2017

Pietro Scalfaro

series ordinal

6

object named as

Pietro Scalfaro

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16557546

retrieved

2 August 2017

Brigitte Rosenwirth

series ordinal

4

object named as

Brigitte Rosenwirth

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16557546

retrieved

2 August 2017

author name string

Artur Kaul

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16557546

retrieved

2 August 2017

language of work or name

English

0 references

publication date

1 April 2006

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16557546

retrieved

2 August 2017

published in

Hepatology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16557546

retrieved

2 August 2017

volume

43

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16557546

retrieved

2 August 2017

issue

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16557546

retrieved

2 August 2017

page(s)

761-770

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16557546

retrieved

2 August 2017

cites work

The non-immunosuppressive cyclosporin A analogue SDZ NIM 811 inhibits cyclophilin A incorporation into virions and virus replication in human immunodeficiency virus type 1-infected primary and growth-arrested T cells

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.21102

retrieved

21 January 2018

Inhibition of human immunodeficiency virus type 1 replication by SDZ NIM 811, a nonimmunosuppressive cyclosporine analog

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.21102

retrieved

21 January 2018

Novel insights into hepatitis C virus replication and persistence

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.21102

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical consequences of hepatitis C virus infection.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.21102

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical trial results of peginterferons in combination with ribavirin

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.21102

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclosporin: an updated review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (neoral)1 in organ transplantation

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.21102

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclophilin interactions with incoming human immunodeficiency virus type 1 capsids with opposing effects on infectivity in human cells

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.21102

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Target cell cyclophilin A modulates human immunodeficiency virus type 1 infectivity

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.21102

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Schistosoma japonicum is less sensitive to cyclosporin A in vivo than Schistosoma mansoni.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.21102

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Synergistic action of cyclosporin A and polyspecific rabbit anti-sera against murine Schistosoma mansoni

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.21102

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

The larvicidal activity of cyclosporin A against Schistosoma mansoni in mice

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.21102

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Suppressive effects of cyclosporin A in murine schistosomiasis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.21102

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Protection against schistosomiasis produced by cyclosporin A

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.21102

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Antischistosomal effects of cyclosporin A

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.21102

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Roles of peptidyl-prolyl cis-trans isomerase and calcineurin in the mechanisms of antimalarial action of cyclosporin A, FK506, and rapamycin

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.21102

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasmodium vivax: in vitro antiparasitic effect of cyclosporins

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.21102

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Specific inhibition of hepatitis C virus replication by cyclosporin A.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.21102

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.21102

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

A pilot study of the combination of cyclosporin A and interferon alfacon-1 for the treatment of hepatitis C in previous nonresponder patients

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.21102

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Interferon combined with cyclosporine treatment as an effective countermeasure against hepatitis C virus recurrence in liver transplant patients with end-stage hepatitis C virus related disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.21102

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Combined interferon alpha2b and cyclosporin A in the treatment of chronic hepatitis C: controlled trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.21102

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Synthetic routes to NEtXaa4-cyclosporin A derivatives as potential anti-HIV I drugs

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.21102

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of hepatitis C virus RNA replication by 2'-modified nucleoside analogs

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.21102

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro studies of cross-resistance mutations against two hepatitis C virus serine protease inhibitors, VX-950 and BILN 2061.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.21102

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro resistance studies of hepatitis C virus serine protease inhibitors, VX-950 and BILN 2061: structural analysis indicates different resistance mechanisms

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.21102

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

A replicon-based bioassay for the measurement of interferons in patients with chronic hepatitis C.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.21102

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Mutations in Hepatitis C Virus RNAs Conferring Cell Culture Adaptation

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.21102

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.21102

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.21102

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Production of infectious hepatitis C virus in tissue culture from a cloned viral genome

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.21102

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Complete replication of hepatitis C virus in cell culture

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.21102

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Enhancement of hepatitis C virus RNA replication by cell culture-adaptive mutations

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.21102

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

A three-dimensional model to analyze drug-drug interactions

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.21102

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Robust hepatitis C virus infection in vitro

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.21102

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Suppression of hepatitis C virus replication by cyclosporin a is mediated by blockade of cyclophilins

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.21102

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclophilin B is a functional regulator of hepatitis C virus RNA polymerase

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.21102

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

DOI

10.1002/HEP.21102

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16557546

retrieved

2 August 2017

PubMed publication ID

16557546

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16557546

retrieved

2 August 2017

ResearchGate publication ID

7220848

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34504825&oldid=1742851639"